Device and method for detecting and treating lesions

US9533176B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9533176-B2
Application numberUS-24913408-A
CountryUS
Kind codeB2
Filing dateOct 10, 2008
Priority dateOct 11, 2007
Publication dateJan 3, 2017
Grant dateJan 3, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A device for treating tissue comprises an enlongate probe and a light delivery unit illuminating a target area with light within a first wavelength band selected to enhance identification of target tissue in combination with an ultrasound crystal mounted at a distal end of the probe, the crystal being stimulated to treat target tissue identified using the light delivery unit.

First claim

Opening claim text (preview).

What is claimed is: 1. A device for treating tissue, comprising: an elongate probe; a light delivery unit supported by the elongate probe for illuminating a target area with light within a first wavelength band selected to enhance identification of target tissue; an ultrasound crystal mounted at a tissue-contacting portion of the probe, the crystal being exposed at a distal end of the probe to directly contact the target tissue, the crystal being stimulated to generate ultrasound energy to treat the target tissue identified using the light delivery unit; and a cooling element for controlling a temperature of the ultrasound crystal, the cooling element delivering a coolant to a chamber over which the ultrasound crystal is mounted. 2. The device according to claim 1 , wherein the first wavelength band is between approximately 385 to 415 nm. 3. The device according to claim 1 , wherein the second wavelength band is between approximately 415 and 445 nm. 4. The device according to claim 1 , wherein the second wavelength band is between approximately 470 and 500 nm. 5. The device according to claim 1 , wherein the light delivery unit illuminates the target area with light within a second wavelength band selected to enhance identification of target tissue. 6. The device according to claim 1 , wherein the ultrasound crystal is stimulated to emit energy in a frequency range of about 3 MHZ to about 20 MHZ. 7. The device according to claim 1 , further comprising a stimulation controller controlling energy supplied to the ultrasound crystal to select a frequency of energy emitted thereby to permit selection of each of a plurality of harmonic frequencies of the ultrasound crystal. 8. The device according to claim 1 , wherein the light delivery unit illuminates the target area with narrow band light with a wavelength between 400 and 500 nm. 9. The device according to claim 1 , wherein the light delivery unit includes at least one optical fiber. 10. The device according to claim 9 , wherein the light delivery unit includes an array of optical fibers. 11. The device according to claim 1 , further comprising a power amplifier and a transformer matching an impedance of the ultrasound crystal to that of the power amplifier. 12. The device according to claim 11 , further comprising a transmission line delivering energy from the power amplifier to the ultrasound crystal. 13. The device according to claim 1 , further comprising an optical sensing element and a light analysis unit for analyzing spectral data of light reflected from the target tissue and supplied to the light analysis unit by the sensing optical element. 14. The device according to claim 1 , further comprising a control unit coupled to the ultrasound crystal controlling energy emitted thereby. 15. The device according to claim 14 , further comprising a light analysis unit analyzing spectral data of light reflected from the target tissue, wherein the control unit is coupled to the light analysis unit to control operation of the ultrasound crystal automatically based on tissue properties determined by the light analysis unit. 16. The device according to claim 15 , further comprising a display outputting data corresponding to the determined tissue properties. 17. The device according to claim 13 , wherein the light analysis unit includes one of a spectrometer and a spectrophotometer. 18. A tissue treatment system, comprising: an elongate shaft with a distal end for insertion into one of a body lumen and a hollow organ; an illumination optical fiber extending to a distal end of the elongate shaft; a sensing optical fiber extending from the distal end; a light source coupled to the illumination optical fiber; a control unit selectively controlling the light source to provide one of a first and a second frequency band of light to the illumination optical fiber, the control unit comprising a light analysis unit coupled to the sensing optical fiber analyzing light received via the sensing optical fiber; an energy delivery element at a tissue-contacting portion of the elongate shaft, the energy delivery element being exposed to directly contact target tissue; and a cooling element for controlling a temperature of the energy delivery element, the cooling element delivering a coolant to a chamber over which the energy delivery element is mounted. 19. The system according to claim 18 , wherein the control unit is coupled to the energy delivery element and controls one of a frequency, intensity and duration of energy delivered to tissue thereby. 20. The system according to claim 18 , wherein a first one of the narrow band filters generates light having a wavelength of between about 400 nm and about 500 nm. 21. The system according to claim 18 , wherein the energy delivery element comprises an ultrasound crystal. 22. The system according to claim 18 , further comprising a selector coupled to the control unit for selecting one of the first and second bands of light to provide to the illumination optical fiber. 23. The system according to claim 1 , wherein the light delivery unit illuminates the target area with light within a second wavelength band selected to enhance identification of the target tissue, and wherein the light delivery unit includes a first narrow band filter for delivering light within the first wavelength band and a second narrow band filter for delivering light within the second wavelength band. 24. The system according to claim 18 , further comprising a plurality of narrow band filters for providing light at one of the first frequency band and the second frequency band.

Assignees

Inventors

Classifications

  • for introduction into the body, e.g. by catheters (A61B5/1459 takes precedence) · CPC title

  • spectrum · CPC title

  • closed, i.e. without wound contact by the fluid · CPC title

  • of the uterine cavities, e.g. uterus, fallopian tubes, ovaries · CPC title

  • A61N7/022Primary

    intracavitary · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9533176B2 cover?
A device for treating tissue comprises an enlongate probe and a light delivery unit illuminating a target area with light within a first wavelength band selected to enhance identification of target tissue in combination with an ultrasound crystal mounted at a distal end of the probe, the crystal being stimulated to treat target tissue identified using the light delivery unit.
Who is the assignee on this patent?
Ostrovsky Isaac, Mcintyre Jon T, Fairneny Ty, and 3 more
What technology area does this patent fall under?
Primary CPC classification A61N7/022. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).